Page 2 - Clinical Connections- Autumn 2021
P. 2
91°µÍø RESEARCH STUDY VETERINARY SERVICES 91°µÍø.AC.UK
for their dogs due to their perceived risks
associated with surgery or due to the
advanced age of their dogs.
The procedure offers a cost-effective
and safe alternative treatment for non-
resectable hepatic tumours. It can improve
the quality of life for patients by shortening
duration of hospitalisation, lowering
pain levels and also stress levels peri-
operatively. It can also improve overall
survival of dogs with hepatic tumours.
Soft tissue surgeon Matteo Rossanese, CT lateral view of the plan for the initial vessel’s catheterisation
who joined the 91°µÍø last year, has
successfully performed the procedure
elsewhere. He has established TACE at
the Queen Mother Hospital for Animals
(QMHA), with the assistance of a grant
from the Animal Care Trust. The grant
allows the team to perform at least four
procedures at a reduced cost for the
clients.
The procedure involves access with a
catheter through an artery on the back leg
of the dog. With the use of tiny catheters
and wires the main vessel feeding the
tumour is selected using fluoroscopy and
a combination of chemotherapy and an
embolic agent is injected into the vessel to
completely occlude it.
Benefits for dogs
Outlining some of the benefit